| Year |
Citation |
Score |
| 2013 |
Omidvar N, Maunakea ML, Jones L, Sevcikova S, Yin B, Himmel KL, Tennant TR, Le Beau MM, Largaespada DA, Kogan SC. PML-RARα co-operates with Sox4 in acute myeloid leukemia development in mice. Haematologica. 98: 424-7. PMID 23144197 DOI: 10.3324/Haematol.2011.057067 |
0.343 |
|
| 2012 |
Stoddart A, Tennant TR, Fernald AA, Anastasi J, Brodsky FM, Le Beau MM. The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice. Oncogene. 31: 494-506. PMID 21706055 DOI: 10.1038/Onc.2011.251 |
0.38 |
|
| 2010 |
Jones L, Wei G, Sevcikova S, Phan V, Jain S, Shieh A, Wong JC, Li M, Dubansky J, Maunakea ML, Ochoa R, Zhu G, Tennant TR, Shannon KM, Lowe SW, et al. Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. The Journal of Experimental Medicine. 207: 2581-94. PMID 21059853 DOI: 10.1084/Jem.20091071 |
0.504 |
|
| 2010 |
Qian Z, Joslin JM, Tennant TR, Reshmi SC, Young DJ, Stoddart A, Larson RA, Le Beau MM. Cytogenetic and genetic pathways in therapy-related acute myeloid leukemia. Chemico-Biological Interactions. 184: 50-7. PMID 19958752 DOI: 10.1016/J.Cbi.2009.11.025 |
0.46 |
|
| 2009 |
Knight JA, Skol AD, Shinde A, Hastings D, Walgren RA, Shao J, Tennant TR, Banerjee M, Allan JM, Le Beau MM, Larson RA, Graubert TA, Cox NJ, Onel K. Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood. 113: 5575-82. PMID 19299336 DOI: 10.1182/Blood-2008-10-183244 |
0.303 |
|
| 2008 |
Jones L, Sevcikova S, Phan V, Jain S, Shieh A, Dubansky J, Li M, Maunakea ML, Zhu G, Tennant TR, Lowe S, Le MM, Kogan SC. Myc Drives Chromosomal Gain in Acute Myeloid Leukemia Blood. 112: 792-792. DOI: 10.1182/Blood.V112.11.792.792 |
0.478 |
|
| 2008 |
Onel K, Knight JA, Skol AD, Tennant TR, Banerjee M, Walgren R, Shao J, Allan JM, Beau MML, Larson RA, Graubert T, Cox NJ. A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia Blood. 112: 432-432. DOI: 10.1182/Blood.V112.11.432.432 |
0.337 |
|
| 2007 |
Joslin JM, Fernald AA, Tennant TR, Davis EM, Kogan SC, Anastasi J, Crispino JD, Le Beau MM. Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood. 110: 719-26. PMID 17420284 DOI: 10.1182/Blood-2007-01-068809 |
0.464 |
|
| 2007 |
Stoddart A, Fernald AA, Tennant TR, Davis EM, Anastasi J, Beau MML. Expression of Alternative CALM-AF10 Fusions Causes Different Hematological Malignancies in Mice. Blood. 110: 2640-2640. DOI: 10.1182/Blood.V110.11.2640.2640 |
0.343 |
|
| 2007 |
Tennant TR, Huo D, Davis EM, Larson RA, Beau MML. Genomic Rearrangements Associated with -5/del(5q) and -7/del(7q) in Myeloid Leukemias. Blood. 110: 1813-1813. DOI: 10.1182/Blood.V110.11.1813.1813 |
0.391 |
|
| 2004 |
Jaeger EB, Chekmareva MA, Tennant TR, Luu HH, Hickson JA, Chen SL, Samant RS, Sokoloff MH, Rinker-Schaeffer CW. Inhibition of prostate cancer metastatic colonization by ∼4.2 Mb of human chromosome 12 International Journal of Cancer. 108: 15-22. PMID 14618610 DOI: 10.1002/Ijc.11483 |
0.383 |
|
| 2001 |
Tennant T, Chekmareva M, Rinker-Schaeffer CW. Northern and southern blotting and the polymerase chain reaction to detect gene expression. Methods in Molecular Medicine. 57: 255-270. PMID 21340903 DOI: 10.1385/1-59259-136-1:255 |
0.392 |
|
| 2000 |
Tennant TR, Rinker-Schaeffer CW, Stadler WM. Angiogenesis inhibitors. Current Oncology Reports. 2: 11-6. PMID 11122819 |
0.53 |
|
| 2000 |
Tennant TR, Kim H, Sokoloff M, Rinker-Schaeffer CW. The Dunning model. The Prostate. 43: 295-302. PMID 10861749 DOI: 10.1002/1097-0045(20000601)43:4<295::Aid-Pros9>3.0.Co;2-W |
0.519 |
|
| Show low-probability matches. |